Part 2 undercover-placement director notice

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

Live 42 CFR 2.67(b) ordinarily requires adequate notice of an undercover-placement application to the Part 2 program director and an opportunity to appear and be heard. That participation is limited to evidence on the statutory and regulatory issuance criteria. The stated notice exceptions concern director involvement or risk that the director would reveal the placement.

Notice protects a limited court role

Under 42 CFR 2.67, the director may present evidence on suspected employee or agent criminal activity, alternative evidence, the public-interest balance, and any post-placement conditions. The court controls the schedule, filing method, confidentiality, and hearing procedure.

The notice record needs exact evidence

Record the application, court, matter, delivery method, recipient authority, delivery date, response deadline, hearing details, counsel, sealing instructions, and proof of service. Keep patient identity outside public captions and routine scheduling messages.

An exception requires its own supported assertion

The application may assert that the director is involved in the suspected activity or would reveal the proposed placement to suspected people. Counsel should preserve the asserted basis and the court's handling rather than turning the exception into a standing agency practice.

Identify the correct director and program

Verify the legal Part 2 program, location, operating entity, current program director, protected contact route, counsel, and any temporary leadership arrangement. Record how each fact was confirmed. A parent-company executive, clinical supervisor, front-desk inbox, or former director may not be the correct recipient.

Keep patient names and treatment facts out of the verification process. Use a restricted legal team when ordinary staff contact could expose the proposed placement.

Prepare adequate protected notice

Follow the court's directions for timing, service, application materials, hearing information, and confidentiality. Explain the limited opportunity to present evidence on the section 2.67 criteria. Use the minimum information needed and protect subject personnel, investigative facts, patient identity, proposed role, and operational details.

Inspect envelopes, email previews, portal alerts, service affidavits, calendars, docket entries, attachments, filenames, and metadata. A sealed application can still be compromised by an identifying notification.

Support the limited hearing opportunity

Provide a workable response deadline, filing or appearance route, accessibility support, and counsel contact as the court requires. Protect submissions, exhibits, remote links, attendance, recordings, transcripts, and evidence. Do not broaden the hearing into patient-record discovery or unrelated operational review.

Preserve notice, delivery, failed delivery, director response, hearing arrangements, court findings, and entered order. Escalate uncertainty or unsafe service before repeating contact.

Apply any exception through the court

If the application asserts that the director is involved in suspected criminal activity or would intentionally or unintentionally disclose the placement, document facts supporting the stated exception. Qualified counsel should present them through the protected application. The investigative team should not treat discomfort, delay, or a general secrecy preference as an automatic exception.

Abstract the court's notice treatment and align implementation with the entered order. Reassess if leadership facts change before placement.

Keep notice separate from placement authority

Completed notice and hearing procedure do not themselves authorize placement. Verify the court's good-cause findings, exact placement authorization, on-site start rule, patient-information limit, disruption safeguards, and patient-use prohibition before operations begin. Link the notice evidence to the correct order version.

Resolve failed or unsafe service

If delivery fails, the recipient changes, or the approved route exposes investigative or patient information, stop routine retry. Preserve the failure, restrict the returned material, and ask counsel to obtain court direction for another protected method. Confirm the corrected service record and hearing time before treating the notice procedure as complete.

Example with notice packets

Seven applications use the ordinary notice route. Six contain verified service, a protected response channel, the limited-purpose explanation, and hearing logistics; one lacks delivery evidence. Notice-packet completeness is 6 of 7 applications.

Owner controls

The 2024 final rule supplies the current text. Use restricted legal intake, director-role verification, court-approved delivery, sealed scheduling, response tracking, hearing evidence, and final order abstraction.

Director-notice checklist

• verify the Part 2 program, current director, protected contact, and counsel;
• follow court-directed timing, service, confidentiality, and filing procedures;
• describe the limited criteria-based opportunity to appear and be heard;
• protect applications, alerts, dockets, submissions, hearings, and transcripts;
• present any stated notice exception to the court with supporting facts; and
• verify the entered order and all operational limits before placement.

Director notice is a protected court procedure, not ordinary business service. Accuracy, confidentiality, and a usable limited response route all matter.